In this section
Noel Cranswick is the Director of the Australian Paediatric Pharmacology Research Unit (APPRU) Director, Clinical Pharmacology, Royal Children’s Hospital (Melbourne) and Associate Professor, Department of Pharmacology, University of Melbourne. Noel has a particular interest in paediatric pharmacokinetics and is familiar both with traditional and sparse data analysis techniques.
He has extensive trial experience in both adult and paediatric clinical trials and has been an investigator on over 100 clinical drug trials and so is familiar with early phase trial methodology and ICH GCP requirements. He has been an advisor to both Government and Industry and continues to evaluate new drug applications for the Australian Therapeutic Drugs Administration.
Noel has also investigated adverse drug reactions (ADR) in a variety of medicines and has an ongoing interest in ADR surveillance and the implementation of research findings into clinical practice.
Internationally he is involved in the World Health Organisation’s Essential Medicines List and was part of the team that initialled the Children’s List. He has also been an adviser to the EMEA on research into paediatric medicines. He has been a co-investigator on both industry and government grants totally over $6M since establishing his centre for research in 1998. He continues to be involved in the development of new medicines for children and the extension of old medicines for novel use in children.